Life Sciences Ontario calls on federal government to delay and reconsider federal price controls as all Canadians focus on COVID efforts

Canada and Ontario’s life sciences sector has been leading unprecedented efforts to respond to the COVID-19 crisis. However, our sector faces an impending challenge – the planned implementation of the Government of Canada’s amendments to the Patented Medicines Regulations. These new regulations threaten to divert our sector’s attention and resources away from the crisis and prevent, ultimately, a much-needed discussion on how to re-ignite Canada’s life sciences sector.

For this reason, Life Sciences Ontario has written a letter to Prime Minister Trudeau requesting a 6-month delay to the July 1st, 2021 implementation date of the Patented Medicines Regulations.